YSOPIA Bioscience leading biotech in the development of innovative microbiome-based therapies

YSOPIA Bioscience, a leading biotech in next-generation microbiome-based therapies that harness the power of keystone single-strain bacteria

more +
lnc
Our Story

Our team is committed to deliver therapeutic solutions to patients with high needs

more +
lnc
therapeutic solutions
lnc

YSOPIA Bioscience is the 1st company to harness the therapeutic potential of Christensenella

Our leadership

Georges RAWADI
Georges RAWADI CEO
Georges RAWADI
CEO

Passionate about innovation

A former researcher at the Institut Pasteur, Georges was Vice-President of Business Development & Intellectual Property and a member of the management team at Celyad.

Sandrine CLAUS
Sandrine CLAUS CSO
Sandrine CLAUS
CSO

Beyond the state of the art

Sandrine joined YSOPIA Bioscience in 2017 as Chief Scientific Officer and is also Associate Professor in Integrative Metabolism in the department of Food and Nutritional Sciences at the University of Reading.

Frédéric Elustondo
Frédéric Elustondo Director of Operations
Frédéric Elustondo
Director of Operations

Execute the right project

Frederic is a trained organic chemist and hold a Ph.D. from the Nottingham University after initial training at the University of Bordeaux.

 
Fabrice GUEZ
Fabrice GUEZ CFO
Fabrice GUEZ
CFO

Putting people first

An experienced CFO, Fabrice decided to switch gears after gaining extensive experience as a financial auditor, getting involved in operations at a number of pharmaceutical SMEs, where he successfully headed up change management processes.

Leveraging partnership for success more +
ICAN
LuinaBio
INRA
Quay Pharma
Cornel University
Bioaster
lnc
Microbiome & us
News
Nov 17, 2020
YSOPIA Bioscience secures €1.55M in non-dilutive funding from Bpifrance and the European Regional Development Fund |...
> more
Oct 13, 2020
We are looking for a R&D Microbiologist | WHAT WE OFFER An exciting opportunity to dive in your career with a...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Publications
Apr 22, 2020
Keystone gut bacteria are the foundation of the whole microbial ecosystem because they provide very specific metabolic...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
now on twitter
YSOPIA Bioscience

.@harvardmed researchers have, for the first time, described in mice how bacteria residing in the gut can protect f… t.co/MLKe5CZNYC

YSOPIA Bioscience © 2020 - all rights reserved terms and conditions Influa | Web Agency © 2018